Yes We Can (Use Nirmatrelvir/Ritonavir Even in High Immunological Risk Patients Treated with Immunosuppressive Drugs)! - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Clinical Pharmacokinetics Année : 2022

Dates et versions

hal-03776307 , version 1 (13-09-2022)

Identifiants

Citer

Florian Lemaitre. Yes We Can (Use Nirmatrelvir/Ritonavir Even in High Immunological Risk Patients Treated with Immunosuppressive Drugs)!. Clinical Pharmacokinetics, 2022, 61 (8), pp.1071-1073. ⟨10.1007/s40262-022-01158-7⟩. ⟨hal-03776307⟩
11 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More